Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-1a in relapsing multiple sclerosis: a randomized, two-arm, open-label, Phase IIIb study

Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-1a in relapsing multiple sclerosis: a randomized, two-arm, open-label, Phase IIIb study

William Camu1, Karim Hadjout2, Sabine Latour3, Dieter Pöhlau4, Said Masri51MS Clinic, CHU Gui de Chauliac, University of Montpellier I, Montpellier, France; 2Department of Neurology, Centre Hospitalier, Rodez, France; 3Merck Serono S.A. – Geneva, Switzerland, an affiliate...

Full description

Bibliographic Details
Main Authors: William Camu, Karim Hadjout, Sabine Latour, et al
Format: Article
Language:English
Published: Dove Medical Press 2010-05-01
Series:Patient Preference and Adherence
Online Access:http://www.dovepress.com/patient-satisfaction-following-transition-from-the-original-to-the-new-a4381

Internet

http://www.dovepress.com/patient-satisfaction-following-transition-from-the-original-to-the-new-a4381

Similar Items